David Pyott, CBE, MD (Hon.)

Dr. Pyott is the former Chairman of the Board and CEO of Allergan Inc. (1998-2015). He grew sales from $1 billion to $7 billion mostly from organic growth. Recognized by Harvard Business Review as one of “The 100 Best Performing CEOs in the World” in 2014 (ranked #4). He has lived in 10 countries and worked in 7 countries in the US, Europe and Asia. In 2006, honored by Her Majesty the Queen with the Commander of the Most Excellent Order of the British Empire (CBE). Education: Master of Arts and an Honorary Degree in Medicine from University of Edinburgh; Master of Business Administration from London Business School; diploma in International and European Law from University of Amsterdam. Directorships: Avery Dennison Corporation; Alnylam Pharmaceuticals; BioMarin Pharmaceutical; Royal Philips in Netherlands; Bioniz Therapeutics; Rani Therapeutics. Advisor: Sienna Biopharmaceuticals and Leerink Investment Bank. Non-Profit: Governor of London Business School; President of International Council of Ophthalmology Foundation; several other US and international eye care charities.